Modified Neck Dissection for Metastatic Testicular Carcinoma

Richard D. Zeph, Edward C. Weisberger, Lawrence Einhorn, Stephen D. Williams, Raleigh E. Lingeman

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Carcinoma of the testicle is a unique clinicopathologic entity in that an optimistic attitude toward cure can be entertained even in the presence of distant metastasis. Chemotherapy, followed by an aggressive surgical resection of residual disease, can result in eradication of this neoplasm. This tumor is capable of being monitored by the use of serum markers, namely, human chorionic gonadotropin and α-fetoprotein. After induction chemotherapy, the transition of elevated serum tumor markers to normal levels suggests that malignant disease has been eliminated or converted to teratoma. Elevated markers indicate persistent or recurrent carcinoma and mandate further chemotherapy. If normalization of tumor markers occurs, any residual mass in the abdomen, chest, or neck should be surgically resected. The otolaryngologist plays a role in the diagnosis and the resection of residual neck disease. Metastatic testicular carcinoma can present as a supraclavicular neck mass and must be considered in the differential diagnosis of a mass in this area. Large residual neck lesions are best removed through the exposure afforded by modified neck dissection. (Arch Otolaryngol 1985;111:667-672)

Original languageEnglish (US)
Pages (from-to)667-672
Number of pages6
JournalArchives of Otolaryngology
Volume111
Issue number10
DOIs
StatePublished - 1985

Fingerprint

Neck Dissection
Neck
Carcinoma
Tumor Biomarkers
Biomarkers
Fetal Proteins
Drug Therapy
Induction Chemotherapy
Teratoma
Chorionic Gonadotropin
Abdomen
Testis
Neoplasms
Differential Diagnosis
Thorax
Neoplasm Metastasis

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Modified Neck Dissection for Metastatic Testicular Carcinoma. / Zeph, Richard D.; Weisberger, Edward C.; Einhorn, Lawrence; Williams, Stephen D.; Lingeman, Raleigh E.

In: Archives of Otolaryngology, Vol. 111, No. 10, 1985, p. 667-672.

Research output: Contribution to journalArticle

Zeph, Richard D. ; Weisberger, Edward C. ; Einhorn, Lawrence ; Williams, Stephen D. ; Lingeman, Raleigh E. / Modified Neck Dissection for Metastatic Testicular Carcinoma. In: Archives of Otolaryngology. 1985 ; Vol. 111, No. 10. pp. 667-672.
@article{3746ffdcff574c97be9bb1296b2833ac,
title = "Modified Neck Dissection for Metastatic Testicular Carcinoma",
abstract = "Carcinoma of the testicle is a unique clinicopathologic entity in that an optimistic attitude toward cure can be entertained even in the presence of distant metastasis. Chemotherapy, followed by an aggressive surgical resection of residual disease, can result in eradication of this neoplasm. This tumor is capable of being monitored by the use of serum markers, namely, human chorionic gonadotropin and α-fetoprotein. After induction chemotherapy, the transition of elevated serum tumor markers to normal levels suggests that malignant disease has been eliminated or converted to teratoma. Elevated markers indicate persistent or recurrent carcinoma and mandate further chemotherapy. If normalization of tumor markers occurs, any residual mass in the abdomen, chest, or neck should be surgically resected. The otolaryngologist plays a role in the diagnosis and the resection of residual neck disease. Metastatic testicular carcinoma can present as a supraclavicular neck mass and must be considered in the differential diagnosis of a mass in this area. Large residual neck lesions are best removed through the exposure afforded by modified neck dissection. (Arch Otolaryngol 1985;111:667-672)",
author = "Zeph, {Richard D.} and Weisberger, {Edward C.} and Lawrence Einhorn and Williams, {Stephen D.} and Lingeman, {Raleigh E.}",
year = "1985",
doi = "10.1001/archotol.1985.00800120061007",
language = "English (US)",
volume = "111",
pages = "667--672",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Modified Neck Dissection for Metastatic Testicular Carcinoma

AU - Zeph, Richard D.

AU - Weisberger, Edward C.

AU - Einhorn, Lawrence

AU - Williams, Stephen D.

AU - Lingeman, Raleigh E.

PY - 1985

Y1 - 1985

N2 - Carcinoma of the testicle is a unique clinicopathologic entity in that an optimistic attitude toward cure can be entertained even in the presence of distant metastasis. Chemotherapy, followed by an aggressive surgical resection of residual disease, can result in eradication of this neoplasm. This tumor is capable of being monitored by the use of serum markers, namely, human chorionic gonadotropin and α-fetoprotein. After induction chemotherapy, the transition of elevated serum tumor markers to normal levels suggests that malignant disease has been eliminated or converted to teratoma. Elevated markers indicate persistent or recurrent carcinoma and mandate further chemotherapy. If normalization of tumor markers occurs, any residual mass in the abdomen, chest, or neck should be surgically resected. The otolaryngologist plays a role in the diagnosis and the resection of residual neck disease. Metastatic testicular carcinoma can present as a supraclavicular neck mass and must be considered in the differential diagnosis of a mass in this area. Large residual neck lesions are best removed through the exposure afforded by modified neck dissection. (Arch Otolaryngol 1985;111:667-672)

AB - Carcinoma of the testicle is a unique clinicopathologic entity in that an optimistic attitude toward cure can be entertained even in the presence of distant metastasis. Chemotherapy, followed by an aggressive surgical resection of residual disease, can result in eradication of this neoplasm. This tumor is capable of being monitored by the use of serum markers, namely, human chorionic gonadotropin and α-fetoprotein. After induction chemotherapy, the transition of elevated serum tumor markers to normal levels suggests that malignant disease has been eliminated or converted to teratoma. Elevated markers indicate persistent or recurrent carcinoma and mandate further chemotherapy. If normalization of tumor markers occurs, any residual mass in the abdomen, chest, or neck should be surgically resected. The otolaryngologist plays a role in the diagnosis and the resection of residual neck disease. Metastatic testicular carcinoma can present as a supraclavicular neck mass and must be considered in the differential diagnosis of a mass in this area. Large residual neck lesions are best removed through the exposure afforded by modified neck dissection. (Arch Otolaryngol 1985;111:667-672)

UR - http://www.scopus.com/inward/record.url?scp=0022348250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022348250&partnerID=8YFLogxK

U2 - 10.1001/archotol.1985.00800120061007

DO - 10.1001/archotol.1985.00800120061007

M3 - Article

C2 - 2412536

AN - SCOPUS:0022348250

VL - 111

SP - 667

EP - 672

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 10

ER -